H&O Biosis
- Biotech or pharma, therapeutic R&D
H&O Biosis is a company dedicated to developing side-effect-free anticancer drugs using natural compound formulations. H&O Biosis is currently focusing on liver cancer among various cancer types.
HO-1197, a natural compound formulation developed by H&O Biosis, not only demonstrates excellent anticancer efficacy but also exhibits low toxicity, allowing for long-term administration with minimal patient discomfort. It offers a multifaceted approach to cancer treatment by inhibiting metastasis and angiogenesis, while also activating the immune system.